ABSTRACT Mixed mono-and tributyrate glycerides have been used for effective delivery of butyrate to the gut to benefit broilers. However, limited information is available on the efficacy of butyrate glycerides individually and in combination with different levels and feeding schedules. The present study has first investigated the effects of monobutyrin at inclusion levels of zero, 500, 1,000, 2,000, and 3,000 ppm on the performance of broilers, and second, the effects of its combination with tributyrin. In the monobutyrin trial, there were no overall significant differences in average daily gain or feed efficiency. However, 2,000 ppm birds had significantly decreased abdominal fat deposition compared to controls (P ≤ 0.05), and the breast muscle deposition increased in a dose-response manner to the supplementation of monobutyrin (P ≤ 0.05). The combination trial tested 5 treatment groups: control, 500 ppm tributyrin + 500 ppm monobutyrin (5T5M), 500 ppm tributyrin + 500 ppm monobutyrin staggered (5T5Ms), 500 ppm tryibutyrin + 2,000 ppm monobutyrin (5T20M), or 500 ppm tributyrin + 2,000 ppm monobutyrin staggered (5T20Ms). In staggered groups, birds were fed tributyrin for one wk followed by 2 wk of monobutyrin, after which the feed was butyrate glyceride free. The non-staggered groups had constant inclusions levels through the 5 weeks. There were no significant differences in average daily gain or feed efficiency among groups. At 5 wk of age, all treatment groups except for 5T5Ms had significantly lower relative abdominal fat weight compared to control birds (P ≤ 0.05), although 5T5Ms birds demonstrated a trend for a decrease (P = 0.095). Relative breast muscle weight was significantly increased only in 5T5M birds over control birds at 5 wk of age (P ≤ 0.05). Serum biochemistry revealed significant changes in factors relating to muscle growth and fat deposition (P ≤ 0.05). These results indicate a consistent shift in lipid metabolism with the addition of butyrate glycerides and that the deposition of breast muscle may be highest with the incorporation of butyrate glycerides at a moderate level for the duration of development.
monobutyrin staggered (5T20Ms). In staggered groups, birds were fed tributyrin for one wk followed by 2 wk of monobutyrin, after which the feed was butyrate glyceride free. The non-staggered groups had constant inclusions levels through the 5 weeks. There were no significant differences in average daily gain or feed efficiency among groups. At 5 wk of age, all treatment groups except for 5T5Ms had significantly lower relative abdominal fat weight compared to control birds (P ≤ 0.05), although 5T5Ms birds demonstrated a trend for a decrease (P = 0.095). Relative breast muscle weight was significantly increased only in 5T5M birds over control birds at 5 wk of age (P ≤ 0.05). Serum biochemistry revealed significant changes in factors relating to muscle growth and fat deposition (P ≤ 0.05). These results indicate a consistent shift in lipid metabolism with the addition of butyrate glycerides and that the deposition of breast muscle may be highest with the incorporation of butyrate glycerides at a moderate level for the duration of development.
INTRODUCTION
Dietary short-chain fatty acids (SCFA) have been demonstrated as feed additives able to control pathogenic bacteria in poultry (Ricke, 2003) . Butyric acid, a 4-carbon SCFA, has been shown to specifically reduce Salmonella colonization in the ceca (Cox et al., 1994; Van Immerseel et al., 2005) , as well as the invasion of Salmonella in the cecal epithelial cells (Van Immerseel et al., 2004) . Using butyric acid in a glyceride form allows for ease of handling, as it does not have the unpleasant odor often associated with free acids, and also facilitates passage to the lower gastrointestinal tract for release via lipase (Sampugna et al., 1967) .
Previous studies have shown that the supplementation of butyric acid derivatives into the diets of broiler chickens could replace antibiotics while maintaining growth performance (Leeson et al., 2005; Namkung et al., 2011) , decrease infection by Salmonella enteritidis (Fernandez-Rubio et al., 2009) , and increase growth performance under stress (Zhang et al., 2011) . Recently, we demonstrated that a mixture of butyrate glycerides (containing mainly mono-and tributyrin, with some dibutyrin) had a positive effect on the performance of broiler chickens, particularly on lipid catabolism (Yin et al., 2016) . To elucidate if an individual butyrate glyceride was responsible for the observed effects, or if a synergistic effect existed, we investigated the effects of solely tributyrin supplementation on broiler performance and found that tributyrin 3221 had no effect on overall growth performance or breast muscle deposition, but reduced abdominal lipid deposition in broiler chickens (Bedford et al., 2016) . Given this, we hypothesized that monobutyrin could provide additional benefits to chicken gut health and growth performance, compared with tributyrin, considering its antimicrobial and angiogenic activities (Namkung et al., 2011; Wilkison and Spiegelman, 1993) , although both butyrins could act synergistically to improve animal performance. The objective of the current study was to extend our previous work by first investigating the effects of monobutyrin supplementation alone on the performance of broiler chickens, and second by combining the levels of both tributyrin and optimal levels of monobutyrin in an effort to establish optimal inclusion levels and feeding duration for both ingredients for broiler chickens.
MATERIALS AND METHODS

Animals and Diets
Trial 1. Due to space limitations, this trial was run in 2 separate experiments (each with a group of untreated birds as a control), each with 240 one-day-old Ross 308 male broilers. In each experiment, the chicks were allocated based on body weight, to minimize initial weight differences between pens, into one of 3 treatments, with 4 replicates of 20 birds per pen, totaling 80 birds per treatment. In experiment 1, the 3 treatments were control (antibiotic-free basal diet), 500 ppm monobutyrin, and 2,000 ppm monobutyrin. In experiment 2, the 3 treatments were control, 1,000 ppm monobutyrin, and 3,000 ppm monobutyrin.
Trial 2. Four hundred one-day-old Ross 308 male broiler chicks were allocated based on weight, to minimize initial weight differences between pens, into one of 5 treatments, with 4 replicates of 20 birds per pen, totaling 80 birds per treatment. The 5 treatments were: 1) control (antibiotic-free basal diet), 2) 500 ppm tributyrin and 500 ppm monobutyrin for the whole period (5T5M), 3) staggered treatment with 500 ppm tributyrin for d one to 7, 500 ppm monobutyrin for d 8 to 21, and no butyrate glycerides for d 21 to 35 (5T5Ms), 4) 500 ppm tributyrin and 2,000 ppm monobutyrin for the whole period (5T20M), and 5) staggered treatment with 500 ppm tributyrin for d one to 7 and 2,000 ppm monobutyrin for d 8 to 21, and no butyrate glycerides for d 21 to 35 (5T20Ms).
For both trials, SN Monobutyrin (Sustainable Nutrition, Alcala de Gurrea, Spain) composed of 60% monobutyrin, 2% di-and tributyrin, 35% free glycerol, 1.6% free butyric acid, and 1.4% water was used as the source of monobutyrin and the inclusions (ppm) were calculated based on 60% monobutyrin in the product. Tributyrin (97%) was obtained from Sigma-Aldrich (St. Louis, MO; Cat. # W222305). Butyrate glycerides were pelleted in with the feed, replacing corn by weight at each respective inclusion level. Birds were fed a starter diet from d one to 15, a grower diet from d 15 to 28, and a finisher diet from d 29 to 35. The basal diets are outlined in Table 1 . Birds were reared in pens (46 ft 2 ), and allowed ad libitum access to feed and water. Birds were maintained at a brooding temperature of 32
• C for 7 d, after which the environmental temperature was gradually reduced to 22
• C from d 7 to d 35. This follows standard brooding practice and standard operating procedures at the Arkell Poultry Research Station, University of Guelph. Chickens were group-weighed weekly, and feed intake was recorded at the same time. Feed:gain ratios were calculated using chicken d per pen, adjusting for chicken mortality. The experimental use of animals and procedures were approved by the University of Guelph's Animal Care Committee in accordance with the Canadian Council on Animal Care's guidelines (Rowsell, 1991) .
Postmortem Sampling
On d 21 and 35 of both trials, for each treatment 2 birds per pen (8 birds per treatment) were randomly selected for sample collection. After weighing, blood samples were collected from the brachial vein of each bird into vaccutainers and kept on ice. Following blood collection, birds were euthanized via cervical dislocation. The abdominal fat pad was removed and weighed. The small intestine was removed, and the length recorded. Following emptying, the small intestine weight was recorded. At the 35 d sampling, the entire breast muscle was removed and weighed.
Blood Analysis
Serum samples were analyzed using a VetScan VS2 (Abaxis, Union City, CA) with the Avian/Reptilian 
Statistical Analysis
The data were statistically analyzed by one-way ANOVA using the MIXED procedure (SAS Release 9.3, SAS Institute Inc., Cary, NC). Significant differences (P ≤ 0.05) among treatment means were identified by the Tukey-Kramer test. The results of abdominal fat or breast muscle weight relative to the body weight also were analyzed by the REG procedure of SAS to determine if a dose response existed.
RESULTS
Growth Performance of Birds Supplemented with Monobutyrin
There were no significant differences in overall average daily gain (ADG) or feed:gain ratio with the addition of monobutyrin to the diets at any level (P > 0.05; Table 2 ); however, there were differences within some of the individual weeks. In wk one, 500 and 2,000 ppm birds had significantly higher feed:gain ratio compared to 1,000 and 3,000 ppm birds (P < 0.05; Table 2 ). In wk 3, 1,000 and 3,000 ppm birds had significantly lower ADG compared to 500 ppm birds and higher feed:gain ratio compared to 500 and 2,000 ppm birds (P < 0.05; Table 2 ). In wk 5, 500 and 2,000 ppm birds had significantly lower ADG compared to 3,000 ppm birds, and 3,000 ppm birds had a significantly lower feed:gain ratio compared to 500 ppm birds (P < 0.05; Table 2 ). Absolute body weight did not differ significantly among groups at any week (P > 0.05; Table 2 ). There were no significant differences in small intestine weight or length relative to body weight with the addition of monobutyrin at 3 or 5 wk of age (P > 0.05; data not shown). At 3 wk of age, there were no significant differences in abdominal fat weight relative to body weight among treated groups and control birds (P > 0.05). At 5 wk of age, 2,000 ppm birds had significantly lower relative abdominal fat weight compared to control birds (P ≤ 0.05; Figure 1 ). Relative breast muscle weight (% of BW) was increased in a dose-dependent manner with the minimum value of 19.624 and the maximum value of 20.828 to the concentrations of monobutyrin supplementation from zero to 3,000 ppm (Y = 19.396 + 0.00435 X; R 2 = 0.171, P-value for the slope = 0.004).
Growth Performance of Birds Supplemented with Monobutyrin/tributyrin Combinations
There were no significant differences in overall ADG or feed:gain between the monobutyrin/tributyrin combinations within individual wk (P > 0.05; Table 3 ). Absolute body weight did not differ significantly among groups at any wk (P > 0.05; Table 3 ). There were no significant differences in small intestine weight or length relative to body weight with the addition of monobutyrin/tributyrin combinations at 3 or 5 wk of age (P > 0.05; data not shown). At 3 wk of age, there was no significant difference in relative abdominal fat weight with the addition of monobutyrin/tributyrin combinations (P > 0.05; Figure 2A ). At 5 wk of age, all monobutyrin/tributyrin combinations except for the group of 5T5Ms resulted in a significant decrease in relative abdominal fat weight compared to control (P ≤ 0.05; Figure 2B) , although 5T5Ms birds demonstrated a trend in the decrease (P = 0.095). Relative breast muscle weight was significantly increased only in 5T5M birds over control birds at 5 wk of age (P ≤ 0.05; Figure 2C ). 2.4030 ± 0.0840 2.5090 ± 0.0915 2.4770 ± 0.0976 2.6257 ± 0.0499 2.4819 ± 0.0717 * Treatments were as follows: control (0 ppm butyrate glycerides), 5T5M (500 ppm tributyrin + 500 ppm monobutyrin), 5T5Ms (500 ppm tributyrin + 500 ppm monobutyrin staggered), 5T20M (500 ppm tryibutyrin + 2,000 ppm monobutyrin), and 5T20Ms (500 ppm tributyrin + 2,000 ppm monobutyrin staggered).
Serum Chemistry of Monobutyrin/tributyrin Treated Birds
Serum phosphorus levels were significantly decreased in control birds at 3 wk of age compared to 5T5Ms birds (2.335 ± 0.148 vs. 2.986 ± 0.023 mmol/L; P < 0.05; Table 4 ). Serum carbon dioxide levels were significantly decreased in both 5T5Ms and 5T20Ms groups compared to control birds at 3 wk of age (P < 0.05; 5T5Ms: 16.25 ± 1.13 mmol/L; 5T20Ms: 18.37 ± 0.46 mmol/L; control: 21.50 ± 0.78 mmol/L; Table 4 ). At 5 wk of age, serum calcium levels were significantly lower in 5T5Ms birds compared to 5T20M birds (2.54 ± 0.03 vs. 2.88 ± 0.05 mmol/L; P < 0.05; Table 5 ). Serum cholesterol levels were significantly lower in 5T5Ms birds compared to control birds at 5 wk of age (3.16 ± 0.09 vs. 3.61 ± 0.13 mmol/L; P < 0.05; Table 5 ), and there was a trend for levels in 5T5M birds to be lower than control birds (3.20 ± 0.08 vs. 3.61 ± 0.13 mmol/L; P < 0.10; Table 5 ). Serum aspartate aminotransferase (AST) levels were significantly increased in 5T5M birds compared to control and 5T5Ms birds at 5 wk of age (P < 0.05; 5T5M: 562.13 ± 58.01 U/L; control: 360.63 ± 36.03 U/L; 5T5Ms: 377.00 ± 38.19 U/L; Table 5 ). There was a trend for 5T5M birds to have higher serum creatine kinase (CK) levels compared to control birds at 5 wk of age (52282.63 ± 3480.20 vs. 24638.13 ± 7584.35 U/L; P < 0.10; Table 5 ).
DISCUSSION
While both tributyrin and monobutyrin have been previously used in broiler production to enhance growth performance, the majority of studies have used butyrate glyceride blends (mono-, di-, and triglycerides). Studies into the effects of incorporating these Abdominal fat weight relative to body weight at 3 wk of age. B. Abdominal fat weight relative to body weight at 5 wk of age. C. Breast muscle weight relative to body weight at 5 wk of age. Different letters denote significant differences (P < 0.05). BW: body weight. Treatments were as follows: control (0 ppm butyrate glycerides), 5T5M (500 ppm tributyrin + 500 ppm monobutyrin), 5T5Ms (500 ppm tributyrin + 500 ppm monobutyrin staggered), 5T20M (500 ppm tryibutyrin + 2,000 ppm monobutyrin), and 5T20Ms (500 ppm tributyrin + 2,000 ppm monobutyrin staggered). n = 8. blends into the diets have shown increased live weight at slaughtering and increased feed conversion (Antongiovanni et al., 2007) , as well as increased breast meat yield and maintained performance through coccidiosis challenge (Leeson et al., 2005) . However, it is unclear how the formulations of these commercial blends were established, or if they are composed of the optimal level of each glyceride. The objective of this study was to determine the optimal inclusion level of monobutyrin, then to test different monobutyrin/tributyrin combinations and feeding schedules to determine if there was an optimal, synergistic effect on the performance of broiler chickens.
Very recently, we investigated the effects of incorporating increasing levels of tributyrin alone into the diets of broiler chickens (Bedford et al., 2016) . The results of this particular study showed that while tributyrin did not have an effect on overall ADG or F:G ratio, there were differences in hepatic gene expression related to lipid metabolism, and a reduction in abdominal fat deposition at both 500 and 2,000 ppm dietary inclusion levels. This was the basis for setting the tributyrin inclusion level at 500 ppm for the current combination study.
The objective of the first trial in this study was to establish the optimal inclusion level of monobutyrin, through the use of SN Monobutyrin, a product containing 60% monobutyrin (with the majority of the rest being glycerol). Pure monobutyrin would be cost prohibitive for use in industry, warranting the use of a glycerol product from manufacturers like SN. Although the results from this study showed no change in overall growth performance of broilers, SN Monobutyrin demonstrated an effect on muscle and lipid deposition, and that 2,000 ppm might be the most promising inclusion level. Similar changes in muscle and lipid deposition were observed by Leeson et al. (2005) when using mixed butyrate glycerides. It is possible that these effects were due to butyrate activity as a histone deacetylase inhibitor, as reported in a previous study with mice in which butyrate both increased muscle fiber crosssectional area and decreased intramuscular fat accumulation (Walsh et al., 2015) .
Building off the first monobutyrin trial, the second trial in the current study used the levels of tributyrin and monobutyrin determined to be best for their respective responses. The inclusion level combinations were tested for the duration of the experiment, and a,b Indicate significant differences within wk (P ≤ 0.05). * Treatments were as follows: control (0 ppm butyrate glycerides), 5T5M (500 ppm tributyrin + 500 ppm monobutyrin), 5T5Ms (500 ppm tributyrin + 500 ppm monobutyrin staggered), 5T20M (500 ppm tryibutyrin + 2,000 ppm monobutyrin), and 5T20Ms (500 ppm tributyrin + 2,000 ppm monobutyrin staggered). Creatine kinase (U/L) 24638 ± 7584 52283 ± 9480 29062 ± 5556 28869 ± 6517 52282 ± 3480 a,b Indicate significant differences within weeks (P ≤ 0.05). * Treatments were as follows: control (0 ppm butyrate glycerides), 5T5M (500 ppm tributyrin + 500 ppm monobutyrin), 5T5Ms (500 ppm tributyrin + 500 ppm monobutyrin staggered), 5T20M (500 ppm tryibutyrin + 2,000 ppm monobutyrin), and 5T20Ms (500 ppm tributyrin + 2,000 ppm monobutyrin staggered). staggered through the first 3 wk of the experiment. Across all treatments, there were no significant differences in ADG, feed:gain, or absolute body weight during individual wk, or overall. Different studies have shown both an improvement (Antongiovanni et al., 2007; Levy et al., 2015; Taherpour et al., 2009) and no change in growth performance with butyrate glyceride supplementation (Leeson et al., 2005; Panda et al., 2009) , suggesting that the effect of butyrate glycerides on broiler chicken growth performance is highly variable.
Consistent across all combination treatment groups was the decrease in abdominal fat weight relative to body weight at 5 wk of age, an effect supported by previous broiler studies with butyrate glycerides (Bedford et al., 2016; Yin et al., 2016) . The results from the staggered treatment groups, in particular, indicate that butyrate glyceride supplementation may not be required through to slaughter weight to obtain this reduction. Further, there was no difference in abdominal fat deposition among combination treatments, suggesting that the minimal inclusion level tested here (5T5Ms) is enough to achieve this reduced deposition. This abdominal fat decrease in combination treatment groups was consistent with the monobutyrin results and also agrees with a previous report by Panda et al. (2009) .
In a previous study from our group with broiler chickens fed mixed butyrate glycerides, decreased fat deposition was found to correspond with changes in serum lipid profiles, as well as the levels of some lipid metabolism related enzymes (Yin et al., 2016 ). In the current study, fewer differences were observed than might have been expected given the observed change in fat deposition. There were no differences in serum glucose or cholesterol levels after 3 wk with any treatment. However, at 5 wk of age, there were insignificant decreases in serum cholesterol in all treatment groups compared to controls, except for 5T5Ms birds that showed a significant decrease. This shift in serum cholesterol could be related to the decreased abdominal fat deposition observed, as a correlation between decreased serum cholesterol levels and decreased abdominal fat deposition in chickens has been previously described (Hermier et al., 1989; Musa et al., 2006) .
At 3 wk of age, an increase in phosphorus was observed in all combination treatment groups over controls, but this increase was significant only in 5T5Ms birds. Additionally, decreased carbon dioxide levels were observed in both staggered treatment groups at 3 wk of age. Both serum phosphorus and serum carbon dioxide levels have been linked to kidney function in chickens (Levinsky and Davidson, 1957; Ritchie et al., 1994) , but whether it was affected in this study remains to be determined. The fact that significant differences were observed only in the staggered groups suggests that when used together, tributyrin and monobutyrin may have an opposing effect on each other when it comes to certain serum biochemistry.
Other serum biochemistry differences at 5 wk of age were detected in the calcium, CK, and AST levels. Calcium and phosphorus levels are often linked, as they are both essential for proper bone growth and maintenance, especially with the modern increased broiler growth rates (Proszkowiec-Wehlarz and Angel, 2013; Rath et al., 2000) , but this link was not observed in the present study. Interestingly, the significant decrease in serum cholesterol was observed in the same group that had a significant decrease in serum calcium (5T5Ms). Previous reports have shown that calcium can help reduce cholesterol levels (Kanyinji and Maeda, 2010) . It is possible that this is what occurred in these birds, leading to the clearance of both from the serum. AST is an enzyme involved in both the degradation and biosynthesis of proteins (Sookoian and Pirola, 2012) , while CK is an enzyme important to muscle activity (Wallimann et al., 2011) . There was an increase in both of these enzymes observed in 5T5M birds, coinciding with a significantly increased breast muscle deposition. Previous studies have linked an increase of both AST and CK with muscle growth, specifically with the high rate of muscle deposition observed in modern broilers (Hocking et al., 1993; Szabo and Milisits, 2007) .
In conclusion, the overall results from the present study support previous findings that dietary butyrate glycerides can have a significant effect on lipid metabolism and deposition, and breast muscle deposition, most effectively at 500 ppm tributyrin and 500 ppm monobutyrin fed continuously through the growth period.
